Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT07364877
PHASE1
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers
Sponsor: Daewon Pharmaceutical Co., Ltd.
View on ClinicalTrials.gov
Summary
Safety and pharmacokinetic characteristics evaluation of DW4421 and DW4421S
Official title: A Randomized, Open-label, Single-dose, 2-sequence, Two-period, Crossover Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics After Administration of DW4421 and DW4421S in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
38
Start Date
2025-12-28
Completion Date
2026-05-18
Last Updated
2026-01-23
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
DW4421
DW4421 or DW4421S
DRUG
DW4421S
DW4421 or DW4421S
Locations (1)
Chungbuk National University Hospital
Cheongju-si, South Korea